Tevogen Bio Leverages Microsoft Partnership to Deliver Machine Learning Based Target Identification to Address Human Papilloma Virus (HPV), Advancing TVGN 920

Ryan Saadi, CEO of Tevogen Bio, emphasizes the pressing need for sustainable healthcare solutions amid soaring U.S. healthcare costs. Tevogen focuses on developing innovative T cell therapies to address critical patient needs, backed by a strong team and intellectual property.